Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/11/2014 04/14/2014 04/15/2014 04/16/2014 04/17/2014 Date
63.06(c) 62.44(c) 63.25(c) 64.39(c) 64.17(c) Last
2 140 072 1 695 751 1 886 008 1 459 473 1 268 750 Volume
-4.00% -0.98% +1.30% +1.80% -0.34% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs. The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Biotechnology
Calendar
05/01Earnings Release
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 594 M
EBIT 2014 -536 M
Net income 2014 -525 M
Finance 2014 134 M
Yield 2014 -
Sales 2015 1 485 M
EBIT 2015 258 M
Net income 2015 282 M
Finance 2015 283 M
Yield 2015 -
PER 2014 -
PER 2015 85,88
EV / Sales 2014 24,9x
EV / Sales 2015 9,87x
Capitalization 14 934 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
1d ago Analysis - Fidelity biotech fund among worst performers in April sell-off
2d ago VERTEX PHARMACEUTICALS : Patent Issued for Inhibitors of Serine Proteases, Parti..
2d ago VERTEX PHARMACEUTICALS : to Announce First Quarter 2014 Financial Results on May..
2d ago VERTEX PHARMACEUTICALS : Studies from Vertex Pharmaceuticals Further Understandi..
2d ago VERTEX PHARMACEUTICALS : "Formulations of ®-1-(2,2-Difluorobenzo Dioxol-5-Yl)-N-..
04/10 VERTEX PHARMACEUTICALS : to Announce First Quarter 2014 Financial Results on May..
04/10 VERTEX PHARMACEUTICALS : Patent Issued for Processes for the Facile Synthesis of..
04/10 VERTEX PHARMACEUTICALS : Patent Issued for Compounds Useful as Inhibitors of Jan..
04/04 Momentum names may see more pain
04/02 VERTEX PHARMACEUTICALS : Patent Issued for Methods for Amplifying Hepatitis C Vi..
04/02 VERTEX PHARMACEUTICALS : Patent Issued for Automated Developer for Immuno-Staine..
04/01 VERTEX PHARMACEUTICALS : S&P 500 Analyst Moves: VRTX
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
Vertex Pharmaceuticals Inc : Income Statement Evolution
More Financials
EPS Revisions
Vertex Pharmaceuticals Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF